Who owns TAKEDA PHARMACEUTICAL CO LTD (TAK)? Elite investor 13F holders

5 tracked elite investors reported holding TAKEDA PHARMACEUTICAL CO LTD as of 2026-09-30, including D.E. Shaw, Renaissance Technologies LLC, Pzena Investment Management, Bridgewater Associates, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive,…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
D.E. ShawTAKEDA PHARMACEUTICAL CO LTDSHARE2026-09-302026-11-16 00:00:0057118255.00 USD3140091.000000SharesaddOriginal filing
Renaissance Technologies LLCTAKEDA PHARMACEUTICAL CO LTDSHARE2026-09-302026-11-12 00:00:0041704213.00 USD2292700.000000SharesreduceOriginal filing
Pzena Investment ManagementTAKEDA PHARMACEUTICAL CO LTDSHARE2026-09-302026-10-30 00:00:00824193.00 USD45310.000000SharesaddOriginal filing
Bridgewater AssociatesTAKEDA PHARMACEUTICAL CO LTDSHARE2026-09-302026-11-16 00:00:00387010.00 USD21276.000000SharesbuyOriginal filing
Ancora Advisors / Ancora HoldingsTAKEDA PHARMACEUTICAL CO LTDSHARE2026-09-302026-11-17 00:00:0079758.00 USD4385.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown